Read alogliptin_benzoate.pdf text version

STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL USAN PRONUNCIATION THERAPEUTIC CLAIM CHEMICAL NAMES 1. Benzonitrile, 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)pyrimidinyl]methyl]-, monobenzoate 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)yl}methyl)benzonitrile monobenzoate 6-[(3R)-3-aminopiperidin-1-yl]-1-(2-cyanobenzyl)-3-methylpyrimidin-2,4(1H,3H)-dione monobenzoate ALOGLIPTIN BENZOATE al" oh glip' tin ben' zoe ate

Treatment of type 2 diabetes

2.

3.

STRUCTURAL FORMULA

O H 3C N N

CN

HOOC

O

N

NH2

MOLECULAR FORMULA MOLECULAR WEIGHT TRADEMARK MANUFACTURER CODE DESIGNATION CAS REGISTRY NUMBER

C18H21N5O2·C7H6O2 461.51 None as yet Takeda Pharmaceutical Company Limited SYR-322 850649-62-6

N08/R60

Information

N05

1 pages

Find more like this

Report File (DMCA)

Our content is added by our users. We aim to remove reported files within 1 working day. Please use this link to notify us:

Report this file as copyright or inappropriate

728110


You might also be interested in

BETA
N05